Home › Rheumatoid Arthritis
Rheumatoid Arthritis clinical trials recruiting in the U.S.
58 studies for Rheumatoid Arthritis are recruiting participants at sites across the United States.
Rheumatoid arthritis (RA) is a form of arthritis that causes pain, swelling, and stiffness in your joints. Your risk increases as you become an older adult.
Cities with the most studies
- Houston, TX11 studies
- New York City, NY10 studies
- Durham, NC8 studies
- Boston, MA7 studies
- Aurora, CO7 studies
- Altoona, PA7 studies
- Dallas, TX7 studies
- Chicago, IL6 studies
- San Diego, CA6 studies
- Plantation, FL6 studies
- Ann Arbor, MI5 studies
- Miami, FL5 studies
- Mesquite, TX5 studies
- West Palm Beach, FL5 studies
- St. Louis, MO4 studies
- Tucson, AZ4 studies
- Mountain View, CA4 studies
- Portland, OR4 studies
- Gainesville, FL4 studies
- Cicero, IL4 studies
- Lake Charles, LA4 studies
- The Woodlands, TX4 studies
- Charlotte, NC4 studies
- Coral Springs, FL4 studies
- Clearwater, FL4 studies
- Arlington, TX4 studies
- Cedar Rapids, IA3 studies
- Denver, CO3 studies
- Kendall, FL3 studies
- Omaha, NE3 studies
- West Covina, CA3 studies
- Santa Monica, CA3 studies
- Baltimore, MD3 studies
- Austin, TX3 studies
- Peoria, AZ3 studies
- Tampa, FL3 studies
- Jacksonville, FL3 studies
- Orlando, FL3 studies
- Jackson, TN3 studies
- Hollywood, FL3 studies
By state
- Alabama5 studies
- Arizona9 studies
- California23 studies
- Colorado10 studies
- Florida21 studies
- Georgia4 studies
- Illinois12 studies
- Iowa3 studies
- Kansas3 studies
- Louisiana5 studies
- Maryland4 studies
- Massachusetts8 studies
- Michigan9 studies
- Minnesota4 studies
- Missouri4 studies
- Nebraska3 studies
- New Jersey3 studies
- New York15 studies
- North Carolina12 studies
- Ohio7 studies
- Oregon4 studies
- Pennsylvania10 studies
- South Carolina5 studies
- Tennessee5 studies
- Texas16 studies
- Virginia6 studies
Recently updated studies
EMPHASYS Cup Positioning in THA With Non-Invasive Navigation (Velys Hip Navigation (VHN))
Recruiting
Ages 21 and older · All sexes · Updated Sep 25, 2026 · NCT06631638A Study to Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions and Subcutaneous Injections of ABBV-519 in Adult Participants With Systemic Lupus Erythematosus (SLE) or Rheumatoid Arthritis (RA)
RecruitingPhase 1
Ages 18 to 75 · All sexes · Updated Sep 25, 2026 · NCT07607964RA-PRO PRAGMATIC TRIAL
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 24, 2026 · NCT04692493Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 23, 2026 · NCT03816345A Study of BMS-986528 in Participants With Refractory Rheumatoid Arthritis
RecruitingPhase 1/2
Ages 18 to 65 · All sexes · Updated Sep 22, 2026 · NCT07412704A Study to Evaluate Different Targeted Therapies for Patients With Rheumatoid Arthritis
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT06972446A Study to Assess the Efficacy and Safety of RO7790121 in Participants With Moderate to Severe Rheumatoid Arthritis Who Have Not Responded to or Who Cannot Tolerate Tumor Necrosis Factor (TNF) and/or Janus Kinase (JAK Inhibitors)
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 21, 2026 · NCT07137598An Extension Study to Assess Long-Term Safety and Efficacy of Afimkibart in Participants With Rheumatoid Arthritis
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 18, 2026 · NCT07620392Study Evaluating Safety, Tolerability, PK/PD of Surovatamig in Adult RA or SLE Participants
RecruitingPhase 1
Ages 18 to 65 · All sexes · Updated Sep 18, 2026 · NCT07201558Exactech Shoulder Post Market Clinical Follow-up Study
RecruitingObservational study
Ages 21 and older · All sexes · Updated Sep 17, 2026 · NCT05603728A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD5492 in Adult Participants With Systemic Lupus Erythematosus or Idiopathic Inflammatory Myopathies or Rheumatoid Arthritis.
RecruitingPhase 1
Ages 18 to 70 · All sexes · Updated Sep 15, 2026 · NCT06916806FT839 in Autoimmune Diseases
RecruitingPhase 1/2
Ages 18 to 70 · All sexes · Updated Sep 2, 2026 · NCT07800871A Phase 2 Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune Diseases
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Aug 21, 2026 · NCT06570798Pain Processing in Inflammatory and Non-Inflammatory Chronic Pain Syndromes
RecruitingObservational studyHealthy volunteers welcome
Ages 18 to 70 · All sexes · Updated Aug 19, 2026 · NCT05277025Phase 1b/2 Study of IV Sarilumab in Adult With RA
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Aug 11, 2026 · NCT07704580Creating Health Course Study for People With Rheumatological Conditions and Mood Disorders
Recruiting
Ages 18 to 100 · All sexes · Updated Aug 10, 2026 · NCT07180537A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2)
RecruitingPhase 1/2
Ages 18 to 75 · All sexes · Updated Aug 7, 2026 · NCT06733935AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Jul 31, 2026 · NCT06991114A Study of AZD0120 in Autoimmune Diseases
RecruitingPhase 1
Ages 18 to 75 · All sexes · Updated Jul 28, 2026 · NCT07295847Phase 1a/b Tolerability of NTR-1011 in Healthy Adults and Adult Patients With SLE and RA
RecruitingPhase 1
Ages 18 to 75 · All sexes · Updated Jul 20, 2026 · NCT07237659The Coronary Artery Calcium and Troponins in Rheumatoid Arthritis (CAT-RA) Study
RecruitingObservational study
Ages 35 to 79 · All sexes · Updated Jul 14, 2026 · NCT07315997A Study of Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants With Severe, Refractory Autoimmune Diseases
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Jul 14, 2026 · NCT07115745Early Rheumatoid Arthritis Lung Disease Study
RecruitingObservational study
Ages 19 to 90 · All sexes · Updated Jul 9, 2026 · NCT03192267Immunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder Arthroplasty
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Jul 9, 2026 · NCT07138898Ultrasound Neuroimmune Modulation in Adults With Rheumatoid Arthritis
Recruiting
Ages 18 and older · All sexes · Updated Jul 7, 2026 · NCT07293871From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.